Gotta V - Search Results

1

[Antiepileptics in women of childbearing age and during pregnancy: comparison of specialized information with the current state of knowledge in Germany and Switzerland].

Winterfeld U, Gotta V, Rothuizen LE, Panchaud A, Rossetti AO, Buclin T. Winterfeld U, et al. Among authors: gotta v. Nervenarzt. 2014 Jun;85(6):738-46. doi: 10.1007/s00115-014-4091-x. Nervenarzt. 2014. PMID: 24861194 German.

2

Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levels.

Gotta V, Widmer N, Montemurro M, Leyvraz S, Haouala A, Decosterd LA, Csajka C, Buclin T. Gotta V, et al. Clin Pharmacokinet. 2012 Mar 1;51(3):187-201. doi: 10.2165/11596990-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22339450

3

Monitoring drug therapy.

Buclin T, Gotta V, Fuchs A, Widmer N, Aronson J. Buclin T, et al. Among authors: gotta v. Br J Clin Pharmacol. 2012 Jun;73(6):917-23. doi: 10.1111/j.1365-2125.2012.04237.x. Br J Clin Pharmacol. 2012. PMID: 22360377 Free PMC article.

4

Systematic review of population pharmacokinetic analyses of imatinib and relationships with treatment outcomes.

Gotta V, Buclin T, Csajka C, Widmer N. Gotta V, et al. Ther Drug Monit. 2013 Apr;35(2):150-67. doi: 10.1097/FTD.0b013e318284ef11. Ther Drug Monit. 2013. PMID: 23503441 Review.

5

Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.

Gotta V, Bouchet S, Widmer N, Schuld P, Decosterd LA, Buclin T, Mahon FX, Csajka C, Molimard M. Gotta V, et al. Leuk Res. 2014 Jul;38(7):764-72. doi: 10.1016/j.leukres.2014.03.023. Epub 2014 Apr 26. Leuk Res. 2014. PMID: 24844604

6

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial.

Gotta V, Widmer N, Decosterd LA, Chalandon Y, Heim D, Gregor M, Benz R, Leoncini-Franscini L, Baerlocher GM, Duchosal MA, Csajka C, Buclin T. Gotta V, et al. Cancer Chemother Pharmacol. 2014 Dec;74(6):1307-19. doi: 10.1007/s00280-014-2599-1. Epub 2014 Oct 9. Cancer Chemother Pharmacol. 2014. PMID: 25297989 Free article. Clinical Trial.

7

Guidance to develop individual dose recommendations for patients on chronic hemodialysis.

Gotta V, Dao K, Rodieux F, Buclin T, Livio F, Pfister M. Gotta V, et al. Expert Rev Clin Pharmacol. 2017 Jul;10(7):737-752. doi: 10.1080/17512433.2017.1323632. Epub 2017 May 22. Expert Rev Clin Pharmacol. 2017. PMID: 28447486 Review.

8

From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure.

Goutelle S, Guidi M, Gotta V, Csajka C, Buclin T, Widmer N. Goutelle S, et al. Among authors: gotta v. Pharmaceutics. 2023 Mar 28;15(4):1081. doi: 10.3390/pharmaceutics15041081. Pharmaceutics. 2023. PMID: 37111566 Free PMC article.

9

Tyrosine kinase inhibitors concentration monitoring in chronic myeloid leukemia.

Widmer N, Gotta V, Haouala A, Decosterd LA. Widmer N, et al. Among authors: gotta v. Leuk Res. 2010 Jun;34(6):698-9. doi: 10.1016/j.leukres.2009.12.009. Epub 2010 Jan 13. Leuk Res. 2010. PMID: 20074797 No abstract available.

10

Long-term prospective population PK study in GIST patients--letter.

Chatelut E, Gandia P, Gotta V, Widmer N. Chatelut E, et al. Among authors: gotta v. Clin Cancer Res. 2013 Feb 15;19(4):949. doi: 10.1158/1078-0432.CCR-12-3445. Epub 2013 Feb 5. Clin Cancer Res. 2013. PMID: 23386693 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page